Understanding dermal drug disposition using TCAT™ – a novel PBPK model

Understanding dermal drug disposition using TCAT™ – a novel PBPK model

Software: GastroPlus®

Scientists from GlaxoSmithKline and Simulations Plus have collaborated to develop a mathematical model, Transdermal Compartmental Absorption & Transit (TCAT™), that allows better understanding of drug penetration through the skin while accounting for the formulation characteristics, evaporation and precipitation effects that influence dermal delivery.